New “Q&A with FDA” podcast available on the current status of oral phenylephrine

https://www.fda.gov/media/177105/download?attachment=&utm_medium=email&utm_source=govdelivery The Current Status of Oral Phenylephrine as a Nasal Decongestant Today, FDA released an episode of the “Q&A with FDA” podcast on the current status of oral phenylephrine as a nasal decongestant. Oral phenylephrine is a common ingredient in nonprescription, over-the-counter cough, cold, allergy, and decongestant products. Last fall, FDA held an advisory committee meeting to discuss whether or not oral phenylephrine is generally recognized as safe and effective for use in these products. Dr. Theresa Michele, Director of the Office of Nonprescription Drug Products at FDA’s Center for Drug Evaluation and Research (CDER) and Dr. Ilisa Bernstein, Senior Vice President for Practice, Policy and Partnerships of the American Pharmacists Association (APhA), spoke with Dr. Sara Roach, Pharmacist with the Division of Drug Information at CDER, to discuss the outcome of this advisory committee meeting and answer some common questions pharmacists and other health care professionals have regarding phenylephrine. Q&A with FDA Podcast https://www.fda.gov/drugs/news-events-human-drugs/qa-fda-podcast?utm_medium=email&utm_source=govdelivery